Investor Stock List
#8,650 by institutional money · Stock

Neuphoria Therapeutics Inc. (NEUP)

Institutional ownership from Q3 2026 Form 13F filings

$2.32
+1.75% today
Market closed. Prices as of Nov 20, 3:41 AM ET
13F holders
19 (−3)
Held by 13F filers, live
$4.1M
Shares held
1,766,421
Share of stock outstanding
32.6%
Net buying in Q3 2026
−$528K
New positions / sold out
5 / 8

Largest holders

19 investors
InvestorSharesValue, live% of their portfoliovs Q2 2026
Lynx1 Capital Management LP875,328$2.0M0.35%Unchanged
AdvisorShares Investments LLC312,895$726K0.10%Added +24%
Vanguard Capital Management LLC173,488$402K<0.1%Unchanged
Shay Capital LLC130,021$302K<0.1%Reduced −17%
Geode Capital Management, LLC50,636$117K<0.1%Added +2%
Ikarian Capital, LLC47,443$110K<0.1%Unchanged
Citadel Advisors LLC
Ken Griffin
44,045$102K<0.1%Reduced −39%
Vanguard Fiduciary Trust Co33,806$78K<0.1%Unchanged
ADAR1 Capital Management, LLC30,000$70K<0.1%Unchanged
Jane Street Group, LLC18,171$42K<0.1%Added +22%
Susquehanna International Group, LLP14,732$34K<0.1%New
Boothbay Fund Management, LLC14,000$32K<0.1%Unchanged
GTS Securities LLC11,487$27K<0.1%New
Merck & Co., Inc.10,027$23K<0.1%Unchanged
UBS Group AG224$520<0.1%Reduced −89%
Morgan Stanley58$135<0.1%Unchanged
Allworth Financial LP41$95<0.1%New
FMR LLC16$37<0.1%New
Barclays Plc3$7<0.1%New